Civil society perspectives on negative biomedical HIV prevention trial results and implications for future trials

AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV

Volumn 24, Issue 10, 2012, Pages 1249-1254

  Essack, Zaynab ^a   Koen, Jennifer ^a   Slack, Catherine ^a   Lindegger, Graham ^a   Newman, Peter A ^b  

^a UNIVERSITY OF KWAZULU NATAL   (South Africa)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

civil society organizations; community engagement; early termination of clinical trials; HIV prevention trials; South Africa

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS VACCINE;

ARTICLE; CLINICAL RESEARCH; ETHICS; FEMALE; HUMAN; INFECTION PREVENTION; MALE; PARTICIPATORY RESEARCH; PREVENTION STUDY; PRIORITY JOURNAL; SOUTH AFRICA;

AIDS VACCINES; BIOMEDICAL RESEARCH; COMMUNICABLE DISEASE CONTROL; EARLY TERMINATION OF CLINICAL TRIALS; FEMALE; HIV INFECTIONS; HUMANS; MALE; NATIONAL HEALTH PROGRAMS; PATIENT PARTICIPATION; PUBLIC-PRIVATE SECTOR PARTNERSHIPS; RESEARCH DESIGN; RESEARCH SUPPORT AS TOPIC; SOUTH AFRICA;

EID: 84864649925     PISSN: 09540121     EISSN: 13600451     Source Type: Journal    
DOI: 10.1080/09540121.2012.656566     Document Type: Article

References (28)

1. Barouch, D.H. 2008. Challenges in the development of an HIV-1 vaccine. Nature, 455: 613-619.
2. Berndtson, K., Daid, T., Tracy, C.S., Bhan, A., Cohen, E.R.M., Upshur, R.E., and, Singer, P.A. 2007. Grand challenges in global health: Ethical, social, and cultural issues based on key information perspectives. PLoS Medicine, 4 (9): e268
3. Bernstein, A. 2008. AIDS and the next 25 years. Science, 320 (5877): 717 (Pubitemid 351929596)
4. Bhan, A., Singh, J.A., Upshur, R.E., Singer, P.A., and, Daar, A.S. 2007. Grand challenges in global health: Engaging civil society organizations in biomedical research in developing countries. PLoS Medicine, 4 (9): 1456-1459. (Pubitemid 47503037)
5. Braun, V., and, Clarke, V. 2006. Using thematic analysis in psychology. Qualitative Research in Psychology, 3: 77-101.
6. Cohen, J. 2007. AIDS research. Promising AIDS vaccine's failure leaves field reeling. Science, 318 (5847): 28-29. (Pubitemid 47538010)
7. Corey, L., McElrath, M.J., and, Kublin, J.G. 2009. Post-step modifications for research on HIV vaccines. AIDS, 23 (1): 3-8.
8. Delisle, H., Roberts, J.H., Munro, M., Jones, L., and, Gyorkos, T.W. 2005. The role of NGOs in global health research for development. Health Research Policy and Systems, 3 (3)
9. Dhalla, S., &, Poole, G. 2011. Motivators of enrolment in HIV vaccine trials: A review of HIV vaccine preparedness studies. AIDS Care 23 11 1430 1447.
10. Forbes, A., &, Mudliar, S. 2009. Preventing prevention trial failures: A case study and lessons for future trials from the 2004 Tenofovir trial in Cambodia. Washington, DC: Global Campaign for Microbicides.
11. Frew, P.M., Mulligan, M.J., Hou, S-I., Chan, K., and, del Rio, C. 2010. Time will tell: Community acceptability of HIV vaccine research before and after the Step Study vaccine discontinuation. Open Access Journal of Clinical Trials, 2: 149-156.
12. Mark, D., Middelkoop, K., Roux, S., Gray, G., Nchabaleng, M., Churchyard, G., and NIAID HIV Vaccine Trials Network. 2009. P15-13. HVTN 503 (Phambili) trial discontinuation of enrolment/vaccination: The impact on trial participant attitudes to vaccine trials and scientific research [Abstract]. Retrovirology, 6 (Suppl 3): 214
13. McGrory, E., Irvin, A., and, Heise, L. 2009. Research Rashomon: Lessons from the Cameroon pre-exposure prophylaxis trial site, Washington, DC: Global Campaign for Microbicides at PATH.
14. Mills, E., Rachlis, B., Wu, P., Wong, E., Wilson, K., &, Singh, S. 2005. Media reporting of tenofovir trials in Cambodia and Cameroon. BMC International Health and Human Rights 5 6.
15. Newman, P.A. 2006. Towards a science of community engagement. The Lancet, 367 (9507): 302
16. Newman, P.A., Daley, A., Halpenny, R., and, Loutfy, M. 2008. Community heroes or high risk pariahs? Reasons for declining to enroll in an HIV vaccine trial. Vaccine, 26: 1091-1097.
17. Newman, P.A., Logie, C., James, L., Charles, T., Maxwell, J., Salam, K., &, Woodford, M. 2011. Speaking the dialect: Understanding public discourse in the aftermath of an HIV vaccine trial shutdown. American Journal of Public Health 101 9, 1749-1758.
18. Newman, P.A., Yim, S., Daley, A., Walisser, R., Halpenny, R., Cunningham, W., and, Loutfy, M. 2011. Once bitten, twice shy: Volunteer perspectives in the aftermath of an early HIV vaccine trial termination. Vaccine, 29 (3): 451-458.
19. Ramjee, G., Govinden, R., Morar, N., and, Mbewu, A. 2007. South Africa's experience of the closure of the Cellulose Sulphate microbicide trial. PLoS Medicine, 4 (7): 1167-1173. (Pubitemid 47196217)
20. Rosengarten, M., and, Michael, M. 2009. The performative function of expectations in translating treatment to prevention: The case of HIV pre-exposure prophylaxis, or PrEP. Social Science and Medicine, 69 (7): 1049-1055.
21. Sanders, D., Labonte, R., Baum, F., and, Chopra, M. 2004. Making research matter: A civil society perspective on health research. Bulletin of the World Health Organization, 82 (10): 757-763. (Pubitemid 39457826)
22. Sekaly, R.P. 2008. The failed HIV Merck vaccine study: A step back or a launching point for future vaccine development?. Journal of Experimental Medicine, 205 (1): 7-12.
23. Silverman, D. 2005. Doing qualitative research: A practical handbook, 2nd ed, London: Sage Publications.
24. Steinbrook, R. 2007. One step forward, two steps back-Will there ever be an AIDS vaccine?. New England Journal of Medicine, 357 (26): 2653-2655.
25. UNAIDS-AVAC. 2011. Good participatory practice: Guidelines for biomedical HIV prevention trials. Retrieved from http://data.unaids.org/pub/manual/2007/ jc1364-good-participatory-guidelines-en.pdf
26. van de Wijgert, J.H.H.M., and, Shattock, R.J. 2007. Vaginal microbicides: Moving ahead after an unexpected setback. AIDS, 21 (18): 2369-2376. (Pubitemid 350145168)
27. West Slevin, K., Ukpong, M., &, Heise, L. 2008. Community engagement in HIV prevention trials: Evolution of the field and opportunities for growth. Paper commissioned by aids2031 Science and Technology Working Group. Retrieved from http://www.aids2031.org/pdfs/aids2031%20preconf%20reading%20- %20community%20engagement%20-west-.pdf
28. Wong, H., &, Levin, A. 2007. The journey towards an AIDS vaccine: Perspectives on conducting trials in developing countries. Policy Research Working Paper. New York: International AIDS Vaccine Initiative.